Charles River Laboratories Endosafe Trillium
 

« Previous article
New Zika Immunoassay...
Next article »
Clear Labs' NGS ...

4th December 2018  Content supplied by: DiaSorin Molecular Diagnostics

FDA Clearance for DiaSorin's New SimplexaGroup B Strep Direct


DiaSorin have received FDA clearance for its new SimplexaGroup B Strep Direct recently launched in the European market. Designed for use on the LIAISON MDX instrument, the new test enables the direct detection of Group B Streptococcus DNA.

The new assay can replace traditional culture testing methods and features an efficient and fast workflow. 

“After the launch few weeks ago in Europe, now the Simplexa Group B Strep Direct is available also in the United States.” said Michelle Tabb, Chief Scientific Officer at DiaSorin Molecular LLC. “Our Group continue to support hospitals and clinical labs worldwide to provide excellent patient care through high-quality molecular assays also in the women’s health testing market all over the world.”


    

Date Published: 4th December 2018

Source article link: View


View full company details


Related news




safe and easy sterility testing patented dual needle unique sterisart septum watch video
 

Data Integrity as an Indicator of Quality Control Issues
 

BioMerieux at PDA 2023
 

Condalab Brochure Download
 

Charles River Webinar Recombinant Cascade Reagent
 

Get our eNewsletter
Over 7,000 microbiology professionals get our weekly eNewsletter - subscribe now and find out why!

LATEST MICROBIOLOGY NEWS

MICROBIOLOGY EVENTS